In vivo measurement of extracellular cyclic AMP in the brain: use in studies of beta-adrenoceptor function in nonanesthetized rats

J Neurochem. 1990 Dec;55(6):1942-9. doi: 10.1111/j.1471-4159.1990.tb05780.x.

Abstract

Microdialysis measurement of extracellular cyclic AMP (cAMP) in the cerebral cortex of conscious rats was evaluated as a method for assessing central beta-adrenoceptor function in vivo. Extracellular levels of the nucleotide were found to average 3 pmol/ml under baseline conditions. Local infusion of the beta-agonists norepinephrine (NE) and isoproterenol produced rapid (3 min) and marked (three- to sevenfold) dose-dependent increases in extracellular cAMP, which were potentiated by the phosphodiesterase inhibitor rolipram, and blocked by the beta-antagonist timolol. Responses to both catecholamines underwent rapid desensitization (6-9 min) and recovered within several hours. Time-course studies revealed that the baseline cAMP level underwent a gradual increase and then a decrease over the course of a single 8-h run, and peaked at 24 h postimplantation. Responses to NE were stable for the first 24 h after implantation, then increased at 48 and 120 h. The causes of the latter changes may include reactions to novelty, local inflammatory responses, and/or reactions of adjacent glial cells to implantation. Overall, the results indicate that the microdialysis-cAMP method can be extended to nonanesthetized animals and may be a useful tool for studying neurotransmission at central adenylate cyclase-coupled membrane receptors during various behavioral states.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anesthesia
  • Animals
  • Brain / metabolism*
  • Chromatography
  • Cyclic AMP / metabolism*
  • Extracellular Space / metabolism*
  • Male
  • Norepinephrine / pharmacology
  • Phosphodiesterase Inhibitors / pharmacology
  • Radioimmunoassay
  • Rats
  • Rats, Inbred Strains
  • Receptors, Adrenergic, beta / physiology*
  • Time Factors
  • Urethane

Substances

  • Phosphodiesterase Inhibitors
  • Receptors, Adrenergic, beta
  • Urethane
  • Cyclic AMP
  • Norepinephrine